Condition

Cardiotoxicity (2)

Dyspnea (1)

HER2/Neu Positive (1)

Metastatic Malignant Neoplasm in the Brain (1)

Multiple Myeloma (1)

Recurrent Breast Carcinoma (1)

Shortness of Breath (1)

Stage IV Breast Cancer AJCC v6 and v7 (1)

Overall Status

Recruiting (2)

Phase

phase 3 (1)

Sponsor

Southwest Oncology Group (1)

University of Chicago (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

blood pressure cuff (1)

blood tests (1)

carvedilol (1)

echocardiogram (1)

endopat (1)

laboratory biomarker analysis (1)

patient observation (1)

quality of life assessment (1)

Study Documents

Intervention Type

other (2)

device (1)

diagnostic test (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

cardiotoxicity

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Tumor in the Brain Trial in Worldwide (Carvedilol, Laboratory Biomarker

Recruiting

Cardiotoxicity
+4 more

Carvedilol
+2 more

Anchorage, Alaska
+579 more

Nov 8, 2021

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who

Recruiting

Multiple Myeloma
+3 more

EndoPAT
+4 more

Chicago, Illinois

University of Chicago

Jun 7, 2021